Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionCity Holding Co
Latest Disclosed Ownership135 shares
Latest Disclosed Value $ 20,620
City Holding Co reports 11.18% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 15, 2026 - City Holding Co filed a 13F-HR form disclosing ownership of 135 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $17,348 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 152 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -11.18% during the quarter. The current value of the position is $16,335 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 -17 -11.18 21 0.00 0.0019
2026-01-22 2025-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 152 0 0.00 21 5.26 0.0026
2025-10-22 2025-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 152 17 12.59 19 18.75 0.0025
2025-07-17 2025-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 0 0.00 16 6.67 0.0021
2025-04-14 2025-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 0 0.00 15 15.38 0.0021
2025-01-16 2024-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 0 0.00 13 -13.33 0.0019
2024-10-08 2024-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 0 0.00 16 7.14 0.0022
2024-07-12 2024-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 135 -410 -75.23 14 -73.08 0.0021
2024-04-11 2024-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 545 -18 -3.20 53 -7.14 0.0079
2024-01-10 2023-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 563 0 0.00 57 -1.75 0.0092
2023-10-13 2023-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 563 -24 -4.09 57 -3.39 0.0102
2023-07-13 2023-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 587 0 0.00 59 9.26 0.0102
2023-04-17 2023-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 587 0 0.00 54 1.89 0.0097
2023-01-27 2022-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 587 -132 -18.36 53 -3.64 0.0099
2022-10-12 2022-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 719 0 0.00 55 -9.84 0.0109
2022-07-08 2022-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 719 0 0.00 61 -3.17 0.0115
2022-04-15 2022-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 719 -31 -4.13 63 -4.55 0.0102
2022-03-11 2021-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 750 -442 -37.08 66 -31.96 0.0110
2021-10-15 2021-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,192 0 0.00 97 -11.01 0.0166
2021-07-15 2021-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,192 -80 -6.29 109 0.00 0.0192
2021-04-15 2021-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 109 -9.17 0.0208
2021-01-12 2020-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 120 8.11 0.0251
2020-10-08 2020-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 111 0.00 0.0253
2020-07-13 2020-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 -14 -1.09 111 4.72 0.0276
2020-04-16 2020-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,286 -57 -4.24 106 -16.54 0.0320
2020-01-10 2019-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,343 0 0.00 127 8.55 0.0301
2019-10-15 2019-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,343 71 5.58 117 0.86 0.0303
2019-07-16 2019-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 116 -4.92 0.0315
2019-04-17 2019-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 122 11.93 0.0344
2019-01-18 2018-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 109 -0.91 0.0356
2018-10-15 2018-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 110 14.58 0.0316
2018-08-20 2018-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 0 0.00 96 -6.80 0.0296
2018-04-12 2018-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,272 29 2.33 103 -0.96 0.0329
2018-01-17 2017-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,243 0 0.00 104 -2.80 0.0329
2017-10-17 2017-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,243 26 2.14 107 4.90 0.0358
2017-07-10 2017-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,217 54 4.64 102 18.60 0.0359
2017-04-20 2017-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,163 0 0.00 86 1.18 0.0322
2017-01-26 2016-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,163 0 0.00 85 -7.61 0.0330
2016-10-11 2016-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,163 31 2.74 92 -1.08 0.0398
2016-07-13 2016-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,132 39 3.57 93 17.72 0.0415
2016-04-20 2016-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,093 0 0.00 79 -15.96 0.0395
2016-01-20 2015-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,093 0 0.00 94 -6.00 0.0484
2015-10-16 2015-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,093 65 6.32 100 -0.99 0.0546
2015-07-13 2015-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,028 0 0.00 101 0.00 0.0514
2015-04-15 2015-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 1,028 31 3.11 101 9.78 0.0515
2015-01-14 2014-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 997 159 18.97 92 16.46 0.0483
2014-10-09 2014-09-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 838 0 0.00 79 8.22 0.0438
2014-08-06 2014-06-30 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 838 561 202.53 73 204.17 0.0420
2014-04-10 2014-03-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 277 57 25.91 24 33.33 0.0146
2014-01-09 2013-12-31 13F NOVARTIS A G SPONSORED ADR FOREIGN EQUITIES 66987V109 220 220 18 0.0113
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.